Emmessar Biotech & Nutrition News

Emmessar Biotech Nutrition Reports Financial Results for Quarter Ended September 30, 2025

Emmessar Biotech Nutrition Limited announced its unaudited financial results for the quarter ended September 30, 2025. The company reported revenue from operations of Rs. 9.26 lakhs for the quarter, compared to Rs. 13.90 lakhs in the previous quarter. The company recorded a net loss after tax of Rs. 3.67 lakhs for the quarter, compared to a net profit of Rs. 30.55 lakhs in the previous quarter. For the half-year period, the company reported revenue of Rs. 23.16 lakhs and net profit after tax of Rs. 26.88 lakhs. The company operates in two segments - Healthcare and Rent on leasehold land. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on November 12, 2025. The company's paid-up equity share capital stands at Rs. 499.61 lakhs with a face value of Rs. 10 per share.